Improving access to care and services
We collaborate with public and private sector organizations to expand access to care and services to improve global health.
Featured stories
-
-
Janssen, the Pharmaceutical Companies of Johnson & Johnson, Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children
Sub-Saharan African Ministries of Health Invited to Submit Expression of Interest to Participate in New EffortDonation Program to be Part of Broader Initiative to Raise Awareness and Action
-
-
Johnson & Johnson secures a top spot on the 2016 Access to Medicine Index
The index looks at companies that do the best job of providing access to medications in developing countries. Johnson & Johnson ranked #2—and here’s why.
More from Johnson & Johnson
-
Why can bipolar disorder go undiagnosed for years?
The condition affects 36 million people around the world, yet it can be surprisingly difficult to recognize—for both patients and healthcare professionals. Learn why Johnson & Johnson continues to advance approaches for this often-misunderstood mental health disorder. -
How a family history of heart disease and stroke drives the work of 3 Johnson & Johnson scientists
Cardiovascular disease is the leading cause of death around the world. For Roberta Chapman, Alistair Lindsay and JoAnne Foody the pursuit of better treatments is both a professional mission and a deeply personal one. -
More than memory loss: 5 things we now know about Alzheimer’s disease
Scientists are better understanding the neuropsychiatric changes that strike up to 97% of patients diagnosed with this degenerative brain disease. Here’s what to know about these often distressing symptoms, and why Johnson & Johnson is working on a solution.
